Sign In
Home
Tavaborole - Tavaborole solution
Get your patient on
Tavaborole - Tavaborole solution
(Tavaborole)
43.5 mg/mL Sol
Prescribing info
PubMed™ news
Tavaborole - Tavaborole solution prescribing information
Data source
Data source
Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
Report Adverse Event
Tavaborole - Tavaborole solution PubMed™ news
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
5 most recent articles for Tavaborole - Tavaborole solution
,
view all articles on PubMed™
Journal Article • 2026 Jul
TiO(2)-Catalyzed Borylation of Haloarenes under Visible Light and Synthesis of Benzoxaboroles.
Journal Article • 2026 Jul
Molecular modeling of 7-propanamide benzoxaboroles as CPSF3 inhibitors through docking-based 3D-QSAR and molecular dynamics simulations.
Journal Article • 2026 Jun
A targeted drug-repurposing strategy identifies Tavaborole (Kerydin) as a potent fungistatic agent against Candida auris.
Journal Article • 2026 Apr
On the mode of anti-C. albicans activity of a bis(benzoxaborole) analogue of tavaborole.
Journal Article • 2026 Apr
Benzoxaborole-Based Inhibitors Block LexA Autocleavage and Suppress SOS-Dependent Adaptive Phenotypes in Escherichia coli.
Show the latest PubMed™ articles for Tavaborole - Tavaborole solution
I certify that I'm a U.S. healthcare provider